Hester Biosciences Ltd

Hester Biosciences Ltd | Sector: Pharmaceuticals | ISIN: INE782E01017

₹ 1,699.00 (0.91%) icon

24 Mar, 2023, 3:29:38 PM
Open
₹ 1,676.35
Prev. Close
₹ 1,683.70
Turnover(lac)
₹ 45.40
Day's High
₹ 1,699.85
Day's Low
₹ 1,664.10
52 Wk High
₹ 2,949.60
52 Wk Low
₹ 1,404.55
Book Value
₹ 346.21
Face Value
₹ 10.00
Mkt. Cap (Cr.)
₹ 1,445.32
P/E
46.10
EPS
36.47
Div. Yield
0.59

Stock View

info icon
Edit Image

HOLD

Target | 06 Feb, 2023

1,830 (8.69%)

Hester Biosciences Limited is an India-based animal healthcare company. The Company is primarily engaged in the production and distribution of vaccines and health products. It is also involv... Read More

KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 3/24/2023 3:29:38 PM

    ₹ 1699 15.30 0.91
  • Open
  • ₹ 1,676.35
  • Prev. Close
  • ₹ 1,683.7
  • Turnover(Lac.)
  • ₹ 45
  • Day's High
  • ₹ 1,699.85
  • Day's Low
  • ₹ 1,664.1
  • 52 Week's High
  • ₹ 2,949.6
  • 52 Week's Low
  • ₹ 1,404.55
  • Book Value
  • ₹ 346.21
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 1,445.32
  • P/E
  • 46.1
  • EPS
  • 36.47
  • Divi. Yield
  • 0.59

Corporate Actions

24 Jan , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

24 Jan , 2023

12:00 AM

22 Oct , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

22 Oct , 2022

12:00 AM

29 Jul , 2022

12:00 AM

AGM

Announcement date: 29 Jul , 2022

View Details

20 May , 2022

12:00 AM

Dividend

Dividend amount: 10
Announcement date: 20 May , 2022

View Details

02 Aug , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

02 Aug , 2022

12:00 AM

12 May , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

07 Apr , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

29 Jul , 2022

12:00 AM

BookCloser

View Details

SHAREHOLDING SNAPSHOT
24 March , 2023 | 08:50 PM

PROMOTER - TOTAL53.73%

Indian: 44.28%

Foreign: 9.4507%

NON-PROMOTER - TOTAL 46.27%

Institutions: 0.49%

Non-Institutions: 45.78%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Hester Biosciences Ltd News and Update

Image not found
  • 14 hours ago |
  • 4:03 PM

According to a BSE filing, the parties to the proposed transaction, for which a legally binding memorandum of understanding had previously been signed, had "executed a Share Purchase Agreement and finalized the transaction."

Article Image
  • IIFL News Service |
  • 1 day ago |
  • 4:02 PM
ad IconAd Image

FINANCIALS

PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Hester Biosciences Ltd

  • Bhupendra V Gandhi

  • Chairman (Non-Executive)
  • Rajiv D Gandhi

  • Managing Director & CEO
  • Sanjiv D Gandhi

  • Non-Exec & Non-Independent Dir
  • Ravin Gandhi

  • Non-Exec & Non-Independent Dir
  • Naman Patel

  • Non-Exec. & Independent Dir.
  • Amit Shukla

  • Non-Exec. & Independent Dir.
  • Vinod Mali

  • Company Sec. & Compli. Officer
  • Nina Gandhi

  • Alternate Director
  • Sandhya Patel

  • Non-Exec. & Independent Dir.
  • Ashok Bhadakal

  • Non-Exec. & Independent Dir.
  • Priya Gandhi

  • Whole Time Director
  • Ameet Desai

  • Independent Director

Summary

Incorporated as a private limited company in Apr.87, Hester Pharmaceutical (HPL) was converted into a public limited company in Nov.93.HPL markets and distributes veterinary and pharmaceutical products like animal health products, poultry vaccines, poultry diagnostic, laboratory kits and reagents. It markets the veterinary products of many international companies including Ghen Corporation, Japan; Maine Biological Laboratories, US; Idexx Corporation, US; International Diagnostic Systems Corporation, US; Biogal Galed Laboratories, Israel; and Kemin Europa, Belgium.The companys own production of veterinary vaccines (in Vials) is expected to commence soon. HPL has technical collaborations with Maine Biological Laboratories and Ghen Corporation.During 1996-97, company successfully implemented veterinary vaccine and commercial production has begun.The company has received licenses for producing 10 additional poultry vaccines.It has also signed an manufacturing agreement with Sinsui Inc for producing poultry... Read More


Reports by Hester Biosciences Ltd


Reports by Hester Biosciences Ltd